Laura Potts

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Laura Potts, is a medical statistician and secondary mathmathetics teacher.[1] As a member of the Mental Health and Neuroscience Clinical Trials Unit, Department of Biostatistics, Institute of Psychiatry, King's College London, London, UK, she served on the trial statisticians team for the controversial PACE trial research.[2]

Since 2015, Potts has been a risk analyst at Bank of Ireland.[1]

Publications[edit | edit source]

  • 2011, Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial[3]
  • 2013, A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan[4]

Letters[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]


Learn more[edit | edit source]

References[edit | edit source]

  1. 1.01.1 "Laura Potts - LinkedIn". LinkedIn. Retrieved Jan 30, 2019. 
  2. White, Peter D.; Sharpe, Michael C.; Chalder, Trudie; DeCesare, Julia C.; Walwyn, Rebecca; PACE trial group (Mar 8, 2007). "Protocol for the PACE trial: a randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise, as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy". BMC neurology. 7: 6. doi:10.1186/1471-2377-7-6. ISSN 1471-2377. PMC 2147058Freely accessible. PMID 17397525. 
  3. White, PD; Goldsmith, KA; Johnson, AL; Potts, L; Walwyn, R; DeCesare, JC; et al. (Mar 5, 2011), "Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial", The Lancet, 377 (9768): 823–836, doi:10.1016/S0140-6736(11)60096-2, PMID 21334061 
  4. Walwyn, Rebecca; Potts, Laura; McCrone, Paul; Johnson, Anthony L.; DeCesare, Julia C.; Baber, Hannah; Goldsmith, Kimberley; Sharpe, Michael; Chalder, Trudie (Nov 13, 2013). "A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan". Trials. 14 (1): 386. doi:10.1186/1745-6215-14-386. ISSN 1745-6215. PMC 4226009Freely accessible. PMID 24225069. 
  5. White, PD; Chalder, T; Sharpe, M; Angus, BJ; Baber, HL; Bavinton, J; Burgess, M; Clark, LV; Cox, DL; DeCesare, JC; Goldsmith, KA; Johnson, AL; McCrone, P; Murphy, G; Murphy, M; O'Dowd, H; Potts, L; Walwyn, R; Wilks, D (Jan 2017). "Response to the editorial by Dr Geraghty". Journal of Health Psychology. 22 (9): 1113–1117. doi:10.1177/1359105316688953. 

Graded exercise therapy (GET) - A gradual increase in exercise or activity, according to a pre-defined plan. Focuses on overcoming the patient's alleged unhelpful illness beliefs that exertion can exacerbate symptoms, rather than on reversing physical deconditioning. Considered controversial, and possibly harmful, in the treatment or management of ME. One of the treatment arms of the controversial PACE trial.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.